The Draths Corp., an Okemos Mich.-based “green” bio-chemical engineering company, announced that it has raised $5 million in Series B funding from Khosla Ventures. peHUB reported on the deal last month, based on a regulatory filing. Draths aims to produce a key building block to anti-influenza drug Tamiflu, and also to develop new anti-influenza drugs to deal with potential viral resistance.
It previously had received a $1 million seed investment from Brad Greenspan, former chairman and CEO of Intermix Media (i.e., MySpace). Greenspan also sits on the Draths board of directors, alongside Samir Kaul of Khosla. www.drathscorporation.com
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.